tiprankstipranks
Trending News
More News >
MEDICLIN AG (DE:MED)
XETRA:MED
Germany Market

MEDICLIN (MED) Ratios

Compare
1 Followers

MEDICLIN Ratios

DE:MED's free cash flow for Q3 2025 was €0.85. For the 2025 fiscal year, DE:MED's free cash flow was decreased by € and operating cash flow was €0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Mar 23Dec 21
Liquidity Ratios
Current Ratio
1.93 1.79 1.75 1.53 1.25
Quick Ratio
1.89 1.75 1.71 1.48 1.21
Cash Ratio
0.71 0.65 0.67 0.52 0.56
Solvency Ratio
0.13 0.11 0.11 0.11 0.11
Operating Cash Flow Ratio
0.59 0.49 0.46 0.20 0.38
Short-Term Operating Cash Flow Coverage
78.71 43.23 2.89 1.29 3.05
Net Current Asset Value
€ -344.57M€ -385.58M€ -384.65M€ -444.78M€ -432.28M
Leverage Ratios
Debt-to-Assets Ratio
0.49 0.51 0.54 0.55 0.50
Debt-to-Equity Ratio
1.81 2.09 2.45 2.40 2.40
Debt-to-Capital Ratio
0.64 0.68 0.71 0.71 0.71
Long-Term Debt-to-Capital Ratio
0.21 0.23 0.25 0.24 0.27
Financial Leverage Ratio
3.68 4.07 4.49 4.38 4.81
Debt Service Coverage Ratio
4.63 3.84 1.95 2.45 2.34
Interest Coverage Ratio
3.01 2.23 0.53 1.84 1.24
Debt to Market Cap
0.40 0.58 0.73 0.55 0.52
Interest Debt Per Share
9.90 10.28 10.61 10.81 9.46
Net Debt to EBITDA
2.71 3.35 3.60 4.52 3.75
Profitability Margins
Gross Profit Margin
84.10%83.20%81.44%81.16%81.86%
EBIT Margin
8.98%7.49%2.09%2.89%1.75%
EBITDA Margin
15.70%14.21%13.87%13.03%12.69%
Operating Profit Margin
8.74%7.14%1.74%2.77%1.72%
Pretax Profit Margin
6.08%4.29%-1.19%1.39%0.36%
Net Profit Margin
4.51%3.32%-1.48%1.34%0.22%
Continuous Operations Profit Margin
4.54%3.33%-1.47%1.38%0.22%
Net Income Per EBT
74.12%77.33%124.02%96.56%59.73%
EBT Per EBIT
69.62%60.05%-68.30%50.09%21.15%
Return on Assets (ROA)
3.85%2.74%-1.22%1.03%0.17%
Return on Equity (ROE)
15.15%11.16%-5.50%4.51%0.80%
Return on Capital Employed (ROCE)
9.10%7.23%1.79%2.62%1.73%
Return on Invested Capital (ROIC)
6.54%5.40%1.55%2.44%0.94%
Return on Tangible Assets
3.95%2.82%-1.26%1.10%0.18%
Earnings Yield
21.33%21.61%-8.40%5.52%0.78%
Efficiency Ratios
Receivables Turnover
4.38 4.17 4.76 5.04 6.04
Payables Turnover
13.68 9.77 10.73 9.16 9.38
Inventory Turnover
17.93 16.41 18.57 14.97 14.34
Fixed Asset Turnover
1.47 1.40 1.42 1.30 1.32
Asset Turnover
0.85 0.83 0.83 0.77 0.76
Working Capital Turnover Ratio
5.38 5.76 6.64 9.81 15.83
Cash Conversion Cycle
77.05 72.41 62.33 56.92 47.00
Days of Sales Outstanding
83.38 87.52 76.68 72.39 60.47
Days of Inventory Outstanding
20.35 22.24 19.65 24.38 25.45
Days of Payables Outstanding
26.68 37.36 34.01 39.84 38.93
Operating Cycle
103.73 109.76 96.34 96.76 85.92
Cash Flow Ratios
Operating Cash Flow Per Share
2.04 1.70 1.64 0.73 1.73
Free Cash Flow Per Share
0.98 0.76 0.85 0.18 1.37
CapEx Per Share
1.06 0.94 0.79 0.55 0.36
Free Cash Flow to Operating Cash Flow
0.48 0.45 0.52 0.25 0.79
Dividend Paid and CapEx Coverage Ratio
1.86 1.80 2.08 1.33 4.82
Capital Expenditure Coverage Ratio
1.93 1.80 2.08 1.33 4.82
Operating Cash Flow Coverage Ratio
0.22 0.17 0.16 0.07 0.19
Operating Cash Flow to Sales Ratio
0.12 0.11 0.11 0.05 0.12
Free Cash Flow Yield
28.29%31.21%31.52%5.04%34.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
4.72 4.63 -11.90 18.11 127.45
Price-to-Sales (P/S) Ratio
0.21 0.15 0.18 0.24 0.28
Price-to-Book (P/B) Ratio
0.67 0.52 0.65 0.82 1.02
Price-to-Free Cash Flow (P/FCF) Ratio
3.55 3.20 3.17 19.84 2.87
Price-to-Operating Cash Flow Ratio
1.71 1.43 1.64 4.94 2.27
Price-to-Earnings Growth (PEG) Ratio
1.10 -0.01 0.06 0.03 -1.10
Price-to-Fair Value
0.67 0.52 0.65 0.82 1.02
Enterprise Value Multiple
4.06 4.43 4.87 6.38 5.93
Enterprise Value
494.83M 471.51M 492.79M 585.63M 506.64M
EV to EBITDA
4.05 4.43 4.87 6.38 5.93
EV to Sales
0.64 0.63 0.67 0.83 0.75
EV to Free Cash Flow
10.64 13.14 12.19 67.93 7.80
EV to Operating Cash Flow
5.12 5.85 6.32 16.91 6.18
Tangible Book Value Per Share
4.71 4.17 3.65 3.24 2.65
Shareholders’ Equity Per Share
5.21 4.68 4.12 4.40 3.86
Tax and Other Ratios
Effective Tax Rate
0.25 0.22 -0.23 <0.01 0.39
Revenue Per Share
16.37 15.76 15.37 14.84 14.17
Net Income Per Share
0.74 0.52 -0.23 0.20 0.03
Tax Burden
0.74 0.77 1.24 0.97 0.60
Interest Burden
0.68 0.57 -0.57 0.48 0.21
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.02 0.02 <0.01 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.74 3.23 -7.24 3.56 55.19
Currency in EUR